Focus Stocks
Abbott's STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
Published on Wednesday, 18 January 2012 08:34 Written by TradersHuddle Staff
ABBOTT PARK, Ill., Jan. 18, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) will begin implementing Abbott's STARLIMS® software-based laboratory information management system (LIMS) as part of the agency's initiative to enhance FDA testing laboratories.
STARLIMS LIMS software will be used to manage complex processes and the analysis of the vast amounts of information generated by FDA laboratories.
As part of a master agreement with Dovel Technologies, a company that provides high-end software applications to government organizations, the FDA's Office of Regulatory Affairs (ORA) will begin deploying LIMS solutions from STARLIMS, designed to enhance testing of food and drug chemistries, devices, forensics material and microbiology samples. The ORA operates mainly five types of laboratories in 14 separate locations. The LIMS solution will provide the needed capability to manage the analytical workflow operations in ORA labs for approximately 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.
"We're looking forward to working on this important initiative," said Isaac Friedman, head of Abbott's STARLIMS business. "STARLIMS has a successful track record in implementing web-based LIMS for life sciences organizations, public health laboratories and a number of federal agencies."
About STARLIMSBased in Hollywood, Fla., Abbott's STARLIMS business (http://www.starlims.com) is a leading provider of laboratory information management systems, with more than 20 years of LIMS experience. STARLIMS products help improve the reliability of laboratory sampling processes, support compliance with domestic and international regulations and industry standards, and provide comprehensive reporting, monitoring and analysis capabilities. STARLIMS software is used for quality assurance and control, testing and monitoring, and research and development in government, manufacturing and life sciences organizations. With 12 development and support centers across the globe, STARLIMS serves customers in more than 40 countries.
About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at www.abbott.com.
SOURCE Abbott
Related Articles
- Abbott Launches PediaSure SideKicks® Clear for Picky Eaters
- Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada
- Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada
- Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
- Abbott Reaches Settlement Agreement on Depakote
- Abbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b Development for Prevention of Acute Kidney Injury
- Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India
- Abbott to Present at Deutsche Bank 37th Annual Health Care Conference
- New Products from Abbott's EAS® Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals
- Abbott and St. Jude Medical Broaden Alliance for Cardiovascular Products in the United States
Related Partner Headlines
- Abbott Laboratories (ABT): Today's Featured Drugs Loser - TheStreet.com
- Abbott Laboratories (ABT): Today's Featured Health Care Winner - TheStreet.com
- Abbott Helps Big Pharma Look Even Worse - TheStreet.com
- Abbott Laboratories (ABT): Today's Featured Health Care Loser - TheStreet.com
- Abbott Reaches Settlement Agreement on Depakote; Will Pay Total of $1.6B - Benzinga
- 10 Best-Performing 'Dividend Aristocrats' - TheStreet.com
- Abbott to Acquire Action Pharma's Investigational Compound, AP214 for $110M - Benzinga
- Abbott Stock Hits New 52-Week High (ABT) - TheStreet.com
- Pfizer Nears Deals for Nutrition, Animal Health Units: Report - TheStreet.com
- More Hep C Drug Abstracts Leak Ahead of EASL Confab - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Market Preview: Feeling the Fear? - TheStreet.com -
Status Quo Is Good for Germany - TheStreet.com -
A Greek Exit Would Cut Both Ways - TheStreet.com -
Royal Dutch Shell PLC ADR (RDS.B): Today's Featured Basic Materials Loser - TheStreet.com -
DIRECTV (DTV): Today's Featured Media Loser - TheStreet.com -
Safeway Inc. (SWY): Today's Featured Retail Loser - TheStreet.com -
Virgin Media Inc (VMED): Today's Featured Services Loser - TheStreet.com -
Celgene Corporation (CELG): Today's Featured Health Care Loser - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,496.15 Trade time:4:05PM EDT Value change:▼6.66 (-0.05%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,318.86 Trade time:4:33PM EDT Value change:▲2.23 (0.17%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,850.12 Trade time:5:16PM EDT Value change:▲11.04 (0.39%)In The Wires
-
Saratoga Investment Corp. Announces Fiscal Fourth Quarter and Year End 2012 Financial Results -
Boeing Conducts Inaugural Flight of First 787 Built in South Carolina -
Post Holdings Schedules Second Quarter 2012 Conference Call -
Strategic Investment in North-East Brazilian Exploration and Mining Company -
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $1 Million Investing in Facebook, Inc. to Contact the Firm -
Skilled Healthcare Group to Present at the Jefferies 2012 Global Healthcare Conference on June 6, 2012 -
Coastal Energy Announces Insider Transactions -
Faruqi & Faruqi, LLP Announces Investigation of Ariba Inc.









